The Role of Endoplasmic Reticulum in Lipotoxicity during Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Pathogenesis

被引:8
|
作者
Venkatesan, Nanditha [1 ]
Doskey, Luke C. [2 ]
Malhi, Harmeet [1 ,3 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
[2] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA
[3] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA
来源
AMERICAN JOURNAL OF PATHOLOGY | 2023年 / 193卷 / 12期
关键词
SIGNAL RECOGNITION PROTEIN; INDUCED ER STRESS; UNFOLDED PROTEIN; LIPID DROPLETS; EXTRACELLULAR VESICLES; HEPATIC LIPOTOXICITY; CONTACT SITES; MEMBRANE; TRANSLOCATION; CERAMIDE;
D O I
10.1016/j.ajpath.2023.08.007
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Perturbations in lipid and protein homeostasis induce endoplasmic reticulum (ER) stress in metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease. Lipotoxic and proteotoxic stress can activate the unfolded protein response (UPR) transducers: inositol requiring enzyme1a, PKR-like ER kinase, and activating transcription factor 6a. Collectively, these pathways induce expression of genes that encode functions to resolve the protein folding defect and ER stress by increasing the protein folding capacity of the ER and degradation of misfolded proteins. The ER is also intimately connected with lipid metabolism, including de novo ceramide synthesis, phospholipid and cholesterol synthesis, and lipid droplet formation. Following their activation, the UPR transducers also regulate lipogenic pathways in the liver. With persistent ER stress, cellular adaptation fails, resulting in hepatocyte apoptosis, a pathological marker of liver disease. In addition to the ER-nucleus signaling activated by the UPR, the ER can interact with other organelles via membrane contact sites. Modulating intracellular communication between ER and endosomes, lipid droplets, and mitochondria to restore ER homeostasis could have therapeutic efficacy in ameliorating liver disease. Recent studies have also demonstrated that cells can convey ER stress by the release of extracellular vesicles. This review discusses lipotoxic ER stress and the central role of the ER in communicating ER stress to other intracellular organelles in MASLD pathogenesis. (Am J Pathol 2023, 193: 1887-1899; https://doi.org/10.1016/j.ajpath.2023.08.007)
引用
收藏
页码:1887 / 1899
页数:13
相关论文
共 50 条
  • [1] Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Shin, Soyeon
    Kim, Jaeyoung
    Lee, Ju Yeon
    Kim, Jun
    Oh, Chang-Myung
    [J]. JOURNAL OF OBESITY & METABOLIC SYNDROME, 2023, 32 (04) : 289 - 302
  • [2] Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Liu, Huan
    Yerevanian, Armen
    Westerhoff, Maria
    Hastings, Margaret H.
    Guerra, Justin Ralph Baldovino
    Zhao, Meng
    Svensson, Katrin J.
    Cai, Bishuang
    Soukas, Alexander A.
    Rosenzweig, Anthony
    [J]. DIABETES, 2024, 73 (02) : 260 - 279
  • [3] Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?
    Kasprzak-Drozd, Kamila
    Nizinski, Przemyslaw
    Kasprzak, Paulina
    Kondracka, Adrianna
    Oniszczuk, Tomasz
    Rusinek, Agata
    Oniszczuk, Anna
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [4] Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Elshaer, Amani
    Chascsa, David M. H.
    Lizaola-Mayo, Blanca C.
    [J]. LIFE-BASEL, 2024, 14 (07):
  • [5] Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
    Chan, Wah-Kheong
    Chuah, Kee-Huat
    Rajaram, Ruveena Bhavani
    Lim, Lee-Ling
    Ratnasingam, Jeyakantha
    Vethakkan, Shireene Ratna
    [J]. JOURNAL OF OBESITY & METABOLIC SYNDROME, 2023, 32 (03) : 197 - 213
  • [6] Evaluation of a Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Clinical Pharmacy Service
    Sallam, Sandy
    Ahmed, Aijaz
    Gu, Xin
    [J]. DIABETES, 2024, 73
  • [7] Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Polyzos, Stergios A.
    Targher, Giovanni
    [J]. CURRENT OBESITY REPORTS, 2024, 13 (02) : 242 - 255
  • [8] Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Ramanathan, Raghu
    Patwa, Sohum A.
    Ali, Ahmad Hassan
    Ibdah, Jamal A.
    [J]. CELLS, 2023, 12 (24)
  • [9] THE PROGNOSTIC ROLE OF THE ELF TEST, COMPARED TO LIVER BIOPSY, IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Liguori, A.
    D'Ambrosio, F.
    Nicholas, V.
    Termite, F.
    Petrucci, L.
    Beschi, R.
    Orienti, M.
    Galletti, S.
    Cardinali, S.
    Riccardi, L.
    Pizzolante, F.
    De, Matthaeis N.
    Zocco, M. A.
    Giustiniani, M. C.
    Marrone, G.
    Biolato, M.
    Cefalo, C.
    Vecchio, F. M.
    Pompili, M.
    Rapaccini, G. L.
    Grieco, A.
    Urbani, A.
    Sanguinetti, M.
    Gasbarrini, A.
    Miele, L.
    [J]. DIGESTIVE AND LIVER DISEASE, 2024, 56 : S257 - S257
  • [10] Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settings
    Iruzubieta, Paula
    Santos-Laso, Alvaro
    Arias-Loste, Maria Teresa
    Calleja, Jose Luis
    Crespo, Javier
    [J]. JOURNAL OF HEPATOLOGY, 2024, 80 (03) : e121 - e123